Amgen Names Robert Bradway Executive Vice President and Chief Financial Officer Read more about Amgen Names Robert Bradway Executive Vice President and Chief Financial Officer
Amgen Discontinues Vectibix(TM) Treatment In PACCE Trial Evaluating Vectibix(TM) As Part Of Triple Combination Regimen Read more about Amgen Discontinues Vectibix(TM) Treatment In PACCE Trial Evaluating Vectibix(TM) As Part Of Triple Combination Regimen
Amgen to Present at the Lehman Brothers Tenth Annual Global Healthcare Conference Read more about Amgen to Present at the Lehman Brothers Tenth Annual Global Healthcare Conference
Amgen to Present at the 27th Annual Cowen & Company Health Care Conference Read more about Amgen to Present at the 27th Annual Cowen & Company Health Care Conference
Amgen Announces Update To U.S. Prescribing Information for Aranesp(R) and EPOGEN(R) Read more about Amgen Announces Update To U.S. Prescribing Information for Aranesp(R) and EPOGEN(R)
Prime Minister Tony Blair Opens Major Amgen Development Centre in London Read more about Prime Minister Tony Blair Opens Major Amgen Development Centre in London
Amgen Announces Proposals to Declassify Board to Be Presented at 2007 Annual Meeting and Adopts Majority Vote Bylaw Read more about Amgen Announces Proposals to Declassify Board to Be Presented at 2007 Annual Meeting and Adopts Majority Vote Bylaw
Amgen to Participate in Oncologic Drugs Advisory Committee in May Read more about Amgen to Participate in Oncologic Drugs Advisory Committee in May
Amgen to Participate in Goldman Sachs 'In Your Office' Call Read more about Amgen to Participate in Goldman Sachs 'In Your Office' Call
Amgen to Hold Analyst Call to Discuss Danish Head and Neck Cancer (DAHANCA) 10 Study Read more about Amgen to Hold Analyst Call to Discuss Danish Head and Neck Cancer (DAHANCA) 10 Study
